Cannabis products manufacturer The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) revealed Wednesday it had obtained authorization to contract or subcontract with a public body from the Autorité des marchés publics (AMP) in Quebec.
SVB Leerink analyst David Risinger initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Outperform rating and announces Price Target of $12.